Introduction: Calyceal diverticula (CD) are traditionally diagnosed by contrast studies. However, non-contrast CT is the standard imaging modality for kidney stones. Therefore, we aimed to determine if the lack of contrast imaging affected outcomes of the management of symptomatic CD with stone. Materials and Methods: This is a retrospective study of patients diagnosed with CD with intracalyceal stone from 2000 to 2017 analyzing demographics, clinical data, and success of different treatment options. The timing of CD diagnosis is correlated to the success of the first treatment. Results: Forty-eight patients were found. CD was diagnosed prior to intervention in 20 (42%) cases and intraoperatively during flexible ureteroscopy in 17 (35%) and 11 (23%) cases were diagnosed after failed intervention, mainly ESWL. We found that the success rate of treatment was highly affected by the timing and modality of diagnosis. Preoperative diagnosis of CD was associated with 69% success rate of the first intervention. In contrast, there was a 0% success rate of first treatment if CD was not diagnosed with contrast imaging. Furthermore, univariate analysis showed no significant association between sociodemographics and clinical variables and success treatment (p > 0.05). Conclusions: The delay in diagnosing CD with stone contributes significantly to the success rate and the number of treatments.

1.
Prather
GC
.
Calyceal diverticulum
.
J Urol
.
1941
;
45
(
1
):
55
64
. .
2.
Middleton
AW
 Jr
,
Pfister
RC
.
Stone-containing pyelocaliceal diverticulum: embryogenic, anatomic, radiologic and clinical characteristics
.
J Urol
.
1974
;
111
(
1
):
2
6
. .
3.
Wulfsohn
MA
.
Pyelocaliceal diverticula
.
J Urol
.
1980
;
123
(
1
):
1
8
. .
4.
Timmons
JW
 Jr
,
Malek
RS
,
Hattery
RR
,
Deweerd
JH
,
Caliceal diverticulum
.
J Urol
.
1975
;
114
(
1
):
6
9
. .
5.
Gross
AJ
,
Herrmann
TR
.
Management of stones in calyceal diverticulum
.
Curr Opin Urol
.
2007
;
17
(
2
):
136
40
. .
6.
Cohen
TD
,
Preminger
GM
.
Management of calyceal calculi
.
Urol Clin North Am
.
1997
;
24
(
1
):
81
96
. .
7.
Worster
A
,
Preyra
I
,
Weaver
B
,
Haines
T
.
The accuracy of noncontrast helical computed tomography versus intravenous pyelography in the diagnosis of suspected acute urolithiasis: a meta-analysis
.
Ann Emerg Med
.
2002
;
40
(
3
):
280
6
. .
8.
Türk
C
,
Petřík
A
,
Sarica
K
,
Seitz
C
,
Skolarikos
A
,
Straub
M
,
EAU guidelines on diagnosis and conservative management of urolithiasis
.
European urology
.
2016
;
69
(
3
):
468
74
. .
9.
Ito
H
,
Aboumarzouk
OM
,
Abushamma
F
,
Keeley
FX
 Jr
.
Systematic review of caliceal diverticulum
.
J Endourol
.
2018
;
32
(
10
):
961
72
. .
10.
Krambeck
AE
,
Lingeman
JE
.
Percutaneous management of caliceal diverticuli
.
J Endourol
.
2009
;
23
(
10
):
1723
9
. .
11.
Türk
C
,
Petřík
A
,
Sarica
K
,
Seitz
C
,
Skolarikos
A
,
Straub
M
,
EAU Guidelines on interventional treatment for urolithiasis
.
Eur Urol
.
2016
;
69
(
3
):
475
82
. .
12.
Rathaus
V
,
Konen
O
,
Werner
M
,
Shapiro Feinberg
M
,
Grunebaum
M
,
Zissin
R
.
Pyelocalyceal diverticulum: the imaging spectrum with emphasis on the ultrasound features
.
Br J Radiol
.
2001
;
74
(
883
):
595
601
. .
13.
Huang
Y
,
Zhang
YH
,
Chi
ZP
,
Huang
R
,
Huang
H
,
Liu
G
,
The handling of oxalate in the body and the origin of oxalate in calcium oxalate stones
.
Urol Int
.
2020
;
104
(
3–4
):
167
76
. .
14.
Saita
A
,
Bonaccorsi
A
,
Motta
M
.
Stone composition: where do we stand?
Urol Int
.
2007
;
79
(
Suppl 1
):
16
9
. .
15.
Michel
W
,
Funke
PJ
,
Tunn
UW
,
Senge
T
.
Pyelocalyceal diverticula
.
Int Urol Nephrol
.
1985
;
17
(
3
):
225
30
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.